How to Get Tagrisso (Osimertinib) Covered by Aetna in Georgia: PA Requirements, Appeals & Scripts
Answer Box: Getting Tagrisso Covered by Aetna in Georgia
Aetna requires prior authorization for Tagrisso (osimertinib) with documented EGFR mutation testing. Submit PA request through CVS Caremark Specialty Pharmacy (1-866-814-5506) with EGFR test results, diagnosis codes, and clinical notes. If denied, you have 180 days to file an internal appeal, then 60 days for Georgia DOI external review. First step today: call Aetna member services to confirm your formulary tier and PA requirements.
Table of Contents
- Plan Types & Coverage Implications
- Formulary Status & Tier Placement
- Prior Authorization Requirements
- Specialty Pharmacy Requirements
- Cost-Share Basics
- Submission Process
- Common Approval Patterns
- Appeals Process in Georgia
- Where to Verify Coverage
- FAQ
Plan Types & Coverage Implications
Aetna offers multiple plan types in Georgia, each with different implications for Tagrisso coverage:
- HMO Plans: Require referrals to oncology specialists; all specialty drugs must go through designated providers
- PPO/EPO Plans: Allow direct access to oncologists; broader network for specialty pharmacy services
- Medicare Plans: Follow CMS guidelines with additional Aetna restrictions
- Medicaid (Georgia Families): Limited formulary with stricter step therapy requirements
Note: Regardless of plan type, Tagrisso requires prior authorization and specialty pharmacy dispensing through CVS Caremark.
Formulary Status & Tier Placement
Tagrisso is placed on Tier 4 (Specialty drugs) in most 2025 Aetna formularies, requiring specialty pharmacy use and higher cost-sharing. The drug is covered for FDA-approved indications but subject to utilization controls.
Coverage Requirements at a Glance
Requirement | Details | Source |
---|---|---|
Prior Authorization | Required for all indications | Aetna PA List |
EGFR Testing | FDA-approved test required | Aetna Clinical Policy |
Specialty Pharmacy | CVS Caremark only | Aetna Specialty Drug List |
Step Therapy | May require erlotinib/gefitinib first | Aetna Drug Guide |
Prior Authorization Requirements
Aetna covers Tagrisso only for specific, well-documented indications with required EGFR mutation testing.
Approved Indications
Medically necessary for:
- First-line metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations
- Combination therapy with pemetrexed and platinum chemotherapy for locally advanced/metastatic NSCLC
- Metastatic EGFR T790M mutation-positive NSCLC after TKI progression
- Adjuvant therapy after tumor resection with EGFR mutations
Required Documentation
- EGFR Mutation Test Results (FDA-approved test)
- Pathology Report confirming NSCLC diagnosis
- Clinical Notes detailing treatment history
- ICD-10 Codes for lung cancer diagnosis
- Prior Therapy Documentation (if applicable)
Clinician Corner: Medical necessity letters should include specific EGFR mutation type, prior treatment failures/intolerances, contraindications to alternatives, and treatment goals aligned with FDA labeling.
Specialty Pharmacy Requirements
All Tagrisso prescriptions must be filled through CVS Caremark Specialty Pharmacy. Patients cannot use retail pharmacies or non-preferred specialty providers.
Setup Process
- Provider submits PA to CVS Caremark Specialty
- Patient enrollment in specialty pharmacy program
- Insurance verification and benefit determination
- Shipment coordination (typically 7-10 days)
CVS Caremark Specialty Contact:
- Phone: 1-866-814-5506 (TTY: 711)
- Fax: 1-866-249-6155
Cost-Share Basics
Tier 4 specialty drugs like Tagrisso typically have the highest cost-sharing under Aetna plans. Patients may face:
- Deductible: Must be met before coverage begins
- Coinsurance: Usually 25-40% of drug cost for specialty tiers
- Out-of-Pocket Maximum: Annual limit on patient costs
Savings Options: AstraZeneca offers patient assistance through AZ&Me Prescription Savings Program for eligible patients.
Submission Process
Step-by-Step: Fastest Path to Approval
- Confirm EGFR Testing (Clinic): Ensure FDA-approved test results are available
- Submit PA Request (Clinic): Call 1-866-814-5506 or submit via provider portal
- Provide Documentation (Clinic): Include all required clinical evidence
- Patient Enrollment (Patient): Complete CVS Caremark specialty pharmacy setup
- Follow Up (Both): Track PA status and respond to requests for additional information
- Appeal if Denied (Both): File internal appeal within 180 days
- External Review (Patient): Request Georgia DOI review within 60 days if internal appeal fails
Timeline: Standard PA decisions typically take 30-45 business days; expedited reviews available for urgent cases (≤72 hours).
Common Approval Patterns
Strong submissions typically include:
- Clear EGFR mutation documentation with specific mutation type
- Treatment history showing appropriate sequencing
- Contraindication evidence if step therapy bypass needed
- Specialist consultation notes from oncology
- Staging information confirming metastatic or adjuvant indication
Common Denial Reasons & Fixes
Denial Reason | How to Overturn |
---|---|
No EGFR mutation documented | Submit FDA-approved test results |
Wrong indication/setting | Clarify adjuvant vs. metastatic use per FDA label |
Step therapy required | Document erlotinib/gefitinib failure or contraindication |
Medical necessity not established | Provide oncologist attestation with clinical rationale |
Appeals Process in Georgia
Georgia provides robust consumer protections for insurance denials through internal appeals and external review.
Internal Appeal Process
- Deadline: 180 days from denial date
- Decision Timeline: 45 business days (standard), 72 hours (expedited)
- Submission: Aetna provider portal or member services
External Review (Georgia DOI)
After internal appeal denial, Georgia residents can request external review:
- Deadline: 60 days from final internal denial
- Process: Independent physician review
- Timeline: 30 business days (standard), 72 hours (expedited)
- Cost: Free to consumer
- Contact: Georgia Department of Insurance, 1-800-656-2298
Important: Georgia's external review decision is binding on Aetna and required by state law.
Counterforce Health helps patients and clinicians navigate complex prior authorization and appeals processes by analyzing denial letters and crafting evidence-backed appeals that align with payer policies and clinical guidelines.
When to Escalate
Contact Georgia DOI Consumer Services if:
- Aetna fails to meet decision deadlines
- Required forms are not provided
- Appeals process seems unfair or incomplete
Georgia DOI Consumer Services: 1-800-656-2298
Where to Verify Coverage
Always confirm current requirements through official sources:
- Aetna Member Portal: Log in to check formulary status
- Member Services: Call number on insurance card
- Provider Portal: Verify PA requirements and submission process
- CVS Caremark: Confirm specialty pharmacy requirements
Key verification points:
- Current formulary tier placement
- PA requirements for your specific plan
- Step therapy obligations
- Quantity limits or other restrictions
FAQ
How long does Aetna PA take in Georgia? Standard decisions take 30-45 business days. Expedited reviews for urgent cases are completed within 72 hours.
What if Tagrisso is non-formulary on my plan? Request a formulary exception with clinical documentation showing medical necessity and lack of suitable alternatives.
Can I request an expedited appeal? Yes, if your health condition poses serious risk with treatment delays. Both internal appeals and external reviews can be expedited.
Does step therapy apply if I failed other TKIs outside Georgia? Yes, but document prior failures/intolerances from any location. Aetna considers treatment history regardless of where it occurred.
What happens if I miss appeal deadlines? You may lose appeal rights. However, if you have good cause for delay (hospitalization, etc.), contact Aetna or Georgia DOI immediately.
Can my doctor handle the appeals process? Yes, with signed authorization. Many oncology practices have staff experienced with Aetna appeals processes.
Sources & Further Reading
- Aetna Clinical Policy for Tagrisso
- Aetna Prior Authorization Lists
- Georgia Department of Insurance Consumer Services
- CVS Caremark Specialty Pharmacy
- AstraZeneca Patient Assistance
- FDA Tagrisso Label
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies change frequently—always verify current requirements with Aetna and consult healthcare providers for medical decisions. For personalized assistance with complex prior authorization and appeals processes, Counterforce Health provides specialized support to help patients and clinicians navigate insurance coverage challenges.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.